Evidence map›Paper›PMID 38271398›Full record

ArticlePLOS global public health2024

Using intervention mapping to develop an implementation strategy to improve timely uptake of streamlined birth-dose vaccines in the Democratic Republic of the Congo.

Alix Boisson-Walsh, Bruce Fried, Christopher M Shea, Patrick Ngimbi, Nana Mbonze, Martine Tabala, Melchior Mwandagalirwa Kashamuka, Pélagie Babakazo, Marcel Yotebieng, Peyton Thompson

Abstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alix Boisson-WalshDepartment of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina, Chapel Hill, North Carolina, United States of America.ORCID https://orcid.org/0000-0002-6180-1931
Bruce FriedDepartment of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina, Chapel Hill, North Carolina, United States of America.
Christopher M SheaDepartment of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina, Chapel Hill, North Carolina, United States of America.
Patrick NgimbiEcole de Santé Publique de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Nana MbonzeEcole de Santé Publique de Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID https://orcid.org/0000-0001-6126-1704
Martine TabalaEcole de Santé Publique de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Melchior Mwandagalirwa KashamukaEcole de Santé Publique de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Pélagie BabakazoEcole de Santé Publique de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Marcel YotebiengDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Peyton ThompsonDivision of Infectious Diseases, Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the policy recommendation and effectiveness of administering the hepatitis B birth-dose vaccine (HepB-BD) to newborns to prevent mother-to-child hepatitis B transmission, timely uptake remains an issue. Countries adopting the HepB-BD to their national immunization schedule report programmatic challenges to administering the vaccine within the recommended 24-hour window after delivery. Further, while the World Health Organization recommends streamlining three birth-dose vaccines (HepB-BD, BCG, and OPV0), scarce Sub-Saharan(SSA)-based literature reports on a streamlined and timely approach to birth-dose vaccines. As more SSA countries adopt the new birth-dose vaccine to their immunization schedules, a systematically developed implementation strategy-Vaccination of Newborns-Innovative Strategies to Hasten Birth-Dose vaccines' delivery (VANISH-BD)-will facilitate the adoption and implementation of timely birth-dose vaccine uptake. In this paper, we describe the development of the implementation strategy using intervention mapping, an evidence-based and theory-driven approach. We report on the development of our intervention, beginning with the needs assessment based in Kinshasa Province, Democratic Republic of the Congo (DRC), informing step 1 of intervention mapping. The intervention is contextually relevant, locally produced, sustainable, and designed to improve timely birth-dose vaccine uptake in the DRC. We intend to inform future implementers about improving timely and streamlined birth-dose vaccine uptake and for VANISH-BD to be adapted for similar contexts.

Identifiers

PMID38271398
PMCPMC10810515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.